Pharminox
Nottingham
About Pharminox
Pharminox is engaged in the discovery, research and development of novel small molecule drugs to treat common forms of cancer, with a specific research focus on molecularly targeted DNA damage and inhibition of DNA damage repair mechanisms.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.2M
- Last round: Grant (May 2012)
- Website: pharminox.com
- Phone: 44-(0)1428-645416
Industries & Categories
Biotechnology, Consulting, Pharmaceutical
Canonical: https://fsome.com/organization/pharminox-3433244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.